InvestorsHub Logo
Followers 62
Posts 7549
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Tuesday, 02/14/2023 9:23:19 AM

Tuesday, February 14, 2023 9:23:19 AM

Post# of 425931
This was a very good shareholder discussion... It pointed out clearly the many strengths of Vascepa(EPA)...
There was a total agreement by the board that the U.S. market is lost...but that doesn't have to be the case...if a BP, with greater assets, could use patented MND-2119 in a FDC to reclaim the U.S, market and still be household name in Europe and ROW.....Amarin , unfortunately, was denied those assets by the decision of judge Du....and now has to sell to a BP.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News